Novartis Posts Mixed Q2 Earnings, Expects Improved Earnings At Sandoz

Novartis has reported a core EPS of $1.56 in Q2 FY22 compared to $1.66 a year ago, beating the consensus of $1.52.
Net sales were $12.78 billion, down 1% Y/Y or up 5% at constant currency (CC), missing the consensus of $13.01 billion.